Literature DB >> 3292697

Immune serum increases arenavirus replication in monocytes.

R M Lewis1, T M Cosgriff, B Y Griffin, J Rhoderick, P B Jahrling.   

Abstract

The U937 monocytic cell line was used to determine whether antibodies could facilitate infection and replication of the arenaviruses, Pichinde virus (PV) and Lassa fever virus (LFV). When high dilutions of PV-immune serum were added to cultures simultaneously with PV inoculum, virus replication was dramatically (1000-fold) increased. Low dilutions of this antiserum neutralized the virus. LFV also replicated in U937 cells. The presence of LFV-specific immune serum in the growth medium increased the viral titre as much as 10,000-fold. Addition of heat-aggregated IgG partially inhibited antibody-mediated enhancement, probably by inhibiting the binding of immune complexes to the monocytic cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292697     DOI: 10.1099/0022-1317-69-7-1735

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice.

Authors:  P Seiler; U Kalinke; T Rülicke; E M Bucher; C Böse; R M Zinkernagel; H Hengartner
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

2.  Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction.

Authors:  K Lunkenheimer; F T Hufert; H Schmitz
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

Review 3.  Neutralizing antiviral antibody responses.

Authors:  R M Zinkernagel; A LaMarre; A Ciurea; L Hunziker; A F Ochsenbein; K D McCoy; T Fehr; M F Bachmann; U Kalinke; H Hengartner
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

4.  Infection of monocytes by human immunodeficiency virus type 1 blocked by inhibitors of CD4-gp120 binding, even in the presence of enhancing antibodies.

Authors:  C F Perno; M W Baseler; S Broder; R Yarchoan
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

Review 5.  A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination.

Authors:  C W Olsen
Journal:  Vet Microbiol       Date:  1993-07       Impact factor: 3.293

6.  Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages.

Authors:  Megan L Heinrich; Matthew L Boisen; Diana K S Nelson; Duane J Bush; Robert W Cross; Anatoliy P Koval; Andrew R Hoffmann; Brandon J Beddingfield; Kathryn M Hastie; Megan M Rowland; Irina Aimukanova; Sophia Koval; Raju Lathigra; Viktoriya Borisevich; Mambu Momoh; John Demby Sandi; Augustine Goba; Lkponmwosa Odia; Francis Baimba; John O Aiyepada; Benevolence Ebo; Philomena Eromon; Chinedu Ugwu; Onikepe Folarin; Testimony Olumade; MacDonald N Onyechi; Johnson Etafo; Rashidat Adeyemi; Elijah E Ella; Maryam Aminu; Simji S Gomerep; Matthew Afam Eke; Olusola Ogunsanya; George O Akpede; Danny O Asogun; Sylvanus A Okogbenin; Peter O Okokhere; Johan Holst; Jeffrey G Shaffer; John S Schieffelin; Thomas W Geisbert; Erica Ollmann Saphire; Christian T Happi; Donald S Grant; Robert F Garry; Luis M Branco
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.